Compare General Dynamics Corporation (GD) vs IDEXX Laboratories, Inc. (IDXX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
General Dynamics Corporation vs IDEXX Laboratories, Inc. — how do they compare? General Dynamics Corporation trades at $392 (market cap $106.03B), while IDEXX Laboratories, Inc. trades at $569.65 (market cap $46.22B). The key difference: General Dynamics Corporation is far larger — about 2.3× IDEXX Laboratories, Inc.'s market cap, and General Dynamics Corporation pays a 1.62% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals.
| GD | IDXX | |
|---|---|---|
Market Cap | $106.03B | $46.22B |
Sector | Industrials | Health |
52-Week High | $395.97 | $766.68 |
52-Week Low | $312.53 | $526.44 |
Enterprise Value | $111.17B | $47.12B |
Dividend Yield | 1.62% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
General Dynamics (GD) trades at $392.68, down 0.83% on the day, amid strong fundamental performance with Q2 2026 EPS beating estimates at $4.24 versus $3.96 expected. The stock shows bullish technical signals with moving averages supporting upward momentum, while fundamentals reveal robust revenue growth to $52.55 billion in 2025 and improving profit margins. Recent contract wins including a $29.5 billion submarine award and a $1.3 billion cybersecurity contract highlight ongoing defense sector strength.
The outlook remains positive with analyst consensus pointing to 8.7% upside to the $427.40 price target, though valuation multiples appear elevated. Key risks include defense budget uncertainties and competitive pressures, while institutional sentiment remains bullish with 57% buy ratings. The company's strong backlog of $136.5 billion provides visibility for future growth.
IDEXX Laboratories (IDXX) trades at $571.44, down 4.08% over the past day, amid a mixed technical and strong fundamental backdrop. The stock shows a bullish trend in moving averages but overbought RSI readings near 73. Recent Q2 2026 earnings beat expectations with 9% organic revenue growth, and the company raised full-year EPS guidance. Profitability remains robust with a 25.03% net income margin and 74.21% ROE.
The outlook is positive given strong earnings momentum, high analyst buy ratings, and a consensus price target of $683.33 implying ~20% upside. Risks include premium valuation multiples and potential market volatility. The stock presents a growth opportunity supported by durable competitive advantages in veterinary diagnostics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About General Dynamics Corporation
General Dynamics is a defense contractor and business jet manufacturer. The firm's segments include aerospace, combat systems, marine, and technologies. The company's aerospace segment creates Gulfstream business jets. Combat system produces land-based combat vehicles, such as the M1 Abrams tank. The marine subsegment creates nuclear-powered submarines, among other things. The technologies segment contains two main units, an IT business that primarily serves the government market and a mission systems business that focuses on products that provide command, control, computers, intelligence, surveillance, and reconnaissance capabilities to the military.
Read more on GD →About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →
